MEDIUM confidence: 100% data completeness, but the composite (51) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Buy-rated share 18% → 11% over ~3 months (-7pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | $0.31 | $0.12 | -61.2% |
| Mar 2026 | $0.47 | $0.58 | +24.5% |
| Dec 2025 | $0.47 | $0.47 | -1.1% |
| Aug 2025 | $0.47 | $0.36 | -24.3% |
| Jun 2025 | $0.34 | $0.31 | -8.8% |
| Mar 2025 | $0.46 | $0.43 | -6.5% |
| Dec 2024 | $0.49 | $0.55 | +12.2% |
| Aug 2024 | $0.46 | $0.41 | -10.9% |
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $3.9B— | $4.2B+7.5% | $4.2B-1.2% | $4.0B-4.9% | $3.9B-1.2% |
| EPS (dil.) | $1.74— | $1.63-6.3% | $2.15+31.9% | $1.84-14.4% | $1.53-16.8% |
| Free Cash Flow | $798M— | $457M-42.7% | $419M-8.3% | $431M+2.9% | $893M+107.2% |
| Gross Margin | 60.8% | 59.0%-1.8pp | 60.5%+1.5pp | 58.9%-1.5pp | 60.5%+1.6pp |
| Operating Margin | 30.6% | 26.7%-4.0pp | 27.5%+0.8pp | 29.4%+1.9pp | 28.2%-1.1pp |
| Net Margin | 21.3% | 18.5%-2.8pp | 24.5%+6.0pp | 21.9%-2.6pp | 18.2%-3.7pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
No recent open-market insider transactions.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 5.1%/yr (revenue basis).
Base free cash flow $581M (avg FY2024–FY2026; latest year $893M) · equity value $13.1B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 51 for Brown-Forman Corporation suggests a neutral outlook, with the stock's strengths and weaknesses balancing out. The company scores high on profitability, driven by a strong ROE of 17.6% and operating margin of 29.0%, but is held back by its value and risk profiles, with a P/E of 18.5 and beta of 0.3 indicating a relatively low-risk but fully valued stock. Growth is a mixed bag, with declining revenue and earnings offset by a surge in free cash flow growth of 107.2%.